Coronavirus | Bombay HC refuses to hear PIL seeking uniform rate of COVID-19 vaccines
The Hindu
“In a situation where the entire country is gripped with the COVID-19 pandemic, price control by the govt is a must and such kind of loot and blackmail should not be permitted,” the PIL said
The Bombay High Court on April 29 refused to hear a PIL seeking a direction to the Serum Institute of India and the Bharat Biotech to sell their COVID-19 vaccines at a uniform rate of ₹150 (plus GST) per dose. The public interest litigation (PIL), filed last week by Mumbai-based advocate Fayzan Khan and three law students, had challenged the different rates of COVID-19 vaccines for the Centre and State governments. The plea was mentioned on April 29 by the petitioner’s advocate, Vivek Shukla, before a Division Bench of Chief Justice Dipankar Datta and Justice G.S. Kulkarni, seeking urgent hearing.More Related News
Deepthi Priya, PG student of AMC, bags gold medal for best research paper. Sunitha of Department of Microbiology bags the second prize, while Krishna Manasa of Department of Biochemistry gets consolation prize. Andhra Medical College hosted the 2024 Prof. Dr. E. Pedaveera Raju Gold Medal for Best Research Paper in Investigative Medicine for PGs in the departments of Pathology, Biochemistry, Microbiology and Radiology.